Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee.

× No keyword cloud information.

18 in total

1. Local coverage determination policy and the use of stereotactic body radiation therapy for prostate cancer.

Authors: Bruce L Jacobs; Robert Sunderland; Jonathan Yabes; Joel B Nelson; Amber E Barnato; Justin E Bekelman
Journal: Urol Pract Date: 2015-11

2. Survey of stereotactic ablative body radiotherapy in the UK by the QA group on behalf of the UK SABR Consortium.

Authors: G Distefano; A Baker; A J D Scott; G J Webster
Journal: Br J Radiol Date: 2014-03-13 Impact factor: 3.039

3. A survey of stereotactic body radiotherapy use in the United States.

Authors: Hubert Pan; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson
Journal: Cancer Date: 2011-03-15 Impact factor: 6.860

4. Radiation treatment for patients with intermediate-risk prostate cancer.

Authors: David E Greene; Jyoti S Mayadev; Richard K Valicenti
Journal: Ther Adv Urol Date: 2012-06

5. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.

Authors: Bruce L Jacobs; Jonathan G Yabes; Samia H Lopa; Dwight E Heron; Chung-Chou H Chang; Florian R Schroeck; Justin E Bekelman; Jeremy M Kahn; Joel B Nelson; Amber E Barnato
Journal: Cancer Date: 2017-03-16 Impact factor: 6.860

Review 6. Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer.

Authors: Giovannalberto Pini; Justin Collins; Pirus Ghadjar; Peter Wiklund
Journal: Curr Urol Rep Date: 2015-05 Impact factor: 3.092

7. Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer.

Authors: Josephine Kang; Bilal Chughtai; Mark N Alshak; Andrew Eidelberg; Susana Martinez Diaz; Michelina D Stoddard; Silvia Formenti; Himanshu Nagar
Journal: World J Urol Date: 2022-02-19 Impact factor: 4.226

Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee.